The FDA has even accredited a drug created with cannabidiol for that function (Epidiolex). But the agency only recommends it for two unusual types of childhood epilepsy called Lennox-Gastaut syndrome and Dravet syndrome.Research will go on to investigate potential therapeutic effects of cannabis to assist inform individual and community health and